期刊文献+

桃红四物汤治疗经期延长的临床研究

Clinical study of Taohong Siwu Decoction in the Treatment of Prolonged Menstrual Period
下载PDF
导出
摘要 目的:分析桃红四物汤治疗经期延长的临床疗效。方法:研究对象选取某院2014年5月~2015年4月收治的88例经期延长患者,应用随机数表法将患者分为研究组和对照组各44例。对照组应用黄体酮胶囊口服治疗,研究组患者使用桃红四物汤治疗,对两组患者的临床疗效和安全性结果进行观察对比。结果:研究组患者的治疗总有效率高于对照组,对比组间差异结果显著(P<0.05);两组患者的不良反应发生率差异较小,结果无显著性(P>0.05)。结论:桃红四物汤治疗经期延长的疗效确切且安全性高,有进一步研究和推广的价值。 Objective: To analyze the clinical dfect of Taohong Siwu decoction in the treatment of prolonged menstrual period.Methods:88 patients with prolonged menstrual period treated in a hospital from May 2014 to April 2015 were selected and divided into study group and control group by random number table method,with 44 patients in each group. The oral administration of progesterone capsules were used in the control group,and the patients in the study group were treated with Taohong Siwu decoction,then the clinical efficacy and safety of two groups of patients were observed and compared.Results:The total effective rate of study group was higher than that of control group, and the difference between the two groups was significant (P〈0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P 〉0.05). Conclusion. Taohong Siwu decoction is effective and safe in the treatment of prolonged menstrual period, which has the value of further research and popularization.
作者 汤传梅
出处 《数理医药学杂志》 2018年第1期77-78,共2页 Journal of Mathematical Medicine
关键词 桃红四物汤 经期延长 临床疗效 Taohong Siwu decoction prolonged menstruation clinical efficacy
  • 相关文献

参考文献5

二级参考文献48

  • 1周迎春,安海燕,赵锋利,陈镜合,朱敏.开心胶囊对大鼠心肌梗死后心脏构筑及左心功能的影响[J].中国临床康复,2005,9(43):90-92. 被引量:4
  • 2张立燕,张大伟,吴学君,张精勇,王瑞华,金星.动脉硬化闭塞症患者股动脉粥样硬化斑块中血小板源生长因子A链的表达[J].中国动脉硬化杂志,2006,14(1):61-63. 被引量:5
  • 3韩岚,许钒,章小兵,史俊,戴敏,彭代银,刘青云.桃红四物汤活血化瘀作用的实验研究[J].安徽中医学院学报,2007,26(1):36-38. 被引量:107
  • 4Born G V R. Aggregation of blood platelets by adenodine diphosphate anditsreversal [ J]. Nature, 1962,194:927.
  • 5van den Borne S W, Isobe S, Verjans J W, et al. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction [ J ]. J Am Coil Cardiol, 2008,52 ( 24 ) : 2017.
  • 6段富津.方剂学[M].上海:上海科学技术出版社,1994.249.
  • 7Moriya J,Minamino T,Tateno K. Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for Limb ischemia[J].Circ Cardiovasc Interv,2009,(3):245-254.
  • 8Aronow WS. Office management of peripheral arterial disease[J].{H}American Journal of Medicine,2010,(9):790-792.
  • 9Selvin E,Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States:results from the National Health and Nutrition Examination Survey 1999-2000[J].{H}CIRCULATION,2004,(6):738-743.
  • 10李日庆;何清湖.中医外科学[M]{H}北京:中国中医药出版社,2012314-318.

共引文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部